JIANGXI BIO(06915.HK) closed 24.49% higher, the Hang Seng Pharmaceuticals & Biotechnology Sector saw divergent trends

NewTimeSpace (newtimespace.com) News, By the close of trading on Jul 24, 2026, JIANGXI BIO(06915.HK) saw a gain of 24.49% in its share price, closing at HKD 12.81. During the session, it reached an intraday high of HKD 14.6 and touched an intraday low of HKD 9.62. The full-day turnover stood at HKD 71.43 million, with significant volume growth, with the latest market capitalization at HKD 3.93 billion.

On the sector front, the Hang Seng Pharmaceuticals & Biotechnology Sector, to which JIANGXI BIO belongs, showed an overall divergence trend, with 34 stocks advancing and 112 stocks declining.Among the gainers, JIANGXI BIO closed higher by 24.49%, NT PHARMA closed higher by 10%, HJ SCIENCE-B closed higher by 9.1%, ALPHAMAB-B closed higher by 4.6%, NEP INTERLONG closed higher by 3.74%.Among the decliners, VIGONVITA-B closed lower by 12.36%, JIUYUAN GENE closed lower by 10.11%, TYK MEDICINES-B closed lower by 8.29%, ZHONGZHIPHARM closed lower by 7.94%, METIS TECHBIO-P closed lower by 7.79%.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.